Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
Precise and easy ways to rewrite human genes could finally provide the tools that researchers need to understand and cure some of our most deadly genetic diseases.
The decision should reduce uncertainty in the field of molecular diagnostics.
A new venture lets patients choose how their data is used for medical research and offers sophisticated privacy settings.
Sequencing a complete human genome may soon cost less than an iPhone. Will BGI-Shenzhen decode yours?
Researchers who have used the biomolecule to encode MP3s, text files, and JPEGs say it will be a competitive storage medium in just a few decades.
A startup called GenePeeks will identify recessive diseases that could show up in children of sperm-bank clients and donors.
A fast, cheap way to identify neuron-to-neuron connections could shed light on disorders including autism and schizophrenia.
A company has developed a simple blood test to identify most cases of autism—but determining if it really works is not so simple.
The blood tests may herald a new wave of noninvasive prenatal screening.